Anavex Life Sciences Corp. (AVXL) vs Immuneering Corporation (IMRX)
A side-by-side comparison of Anavex Life Sciences Corp. and Immuneering Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVXL
Anavex Life Sciences Corp.
$1.61HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
IMRX
Immuneering Corporation
$3.94HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
Total return — AVXL vs IMRX
growth of $100 · dividends reinvested · last 5yAVXL -90.8% (-38.0%/yr)IMRX -77.0% (-25.5%/yr)IMRX compounded faster over this window
AVXL IMRX
AVXL vs IMRX: by the numbers
- •AVXL is the larger company ($149M vs $143M market cap).
Metrics side by side
Valuation
| Metric | AVXL | IMRX |
|---|---|---|
| P/B ratio | 1.33 | 0.75 |
Profitability
| Metric | AVXL | IMRX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -21.38% | -30.03% |
| ROIC | -27.25% | -32.73% |
Growth (annualized)
| Metric | AVXL | IMRX |
|---|---|---|
| Total return CAGR (5Y) | -37.74% | -32.77% |
Frequently asked
- How have AVXL and IMRX total returns compared?
- Over the past 5 years, AVXL delivered -37.74% and IMRX delivered -32.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.